Telephone sharing button Contact Us linkedin sharing button Share wechat sharing button Share mailbox sharing button info@wuxibiologics.com
arrow_left sharing button
arrow_right sharing button

Locations

Total estimated capacity for biopharmaceutical production in China, Ireland, the U.S., Germany and Singapore to exceed 280,000 liters by 2023.

United States
Massachusetts
U.S.
107,000sq. ft.
Operational2022
New Jersey
U.S.
66,000sq. ft.
Operational2020
Pennsylvania
U.S.
33,000sq. ft.
Operational2020
Ireland
Dundalk
Ireland
26Hectare campus
Operations2021
WuXi Vaccines
Ireland
$240Million investment
Operational2022
Germany
Leverkusen
Germany
13,000+sq.m. facility
Operations2020
Singapore
Singapore
$60Million investment
Operational2022
China
Shanghai
Waigaoqiao Free Trade Zone
17,748sq. m.
openedOctober 2011
Shanghai
Fengxian District
1.6 millionsq. ft.
Planned2021
Wuxi
15,296sq.m.
OpenedOctober 2012
Suzhou
10,100sq. m.
OpenedDecember 2014
Hangzhou
30,000sq. m.
Operational2020
Chengdu
314,000sq. m.
Planned2023
Shijiazhuang
82,160sq. m.
Planned2022
Notice:

You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?